Batch distribution studies show that above ~1 M HNO3 Np(IV) and Np(VI) are well extracted into a solvent of 0.2 M TODGA/0.5 M DMDOHEMA in kerosene that has been formulated for the extraction of transuranic actinides in the GANEX (grouped actinide extraction) process. Np(IV) and Np(VI) are quite stable in the solvent phase, although Np(VI) is slowly reduced to Np(IV) on standing. Stripping of Np(IV,VI) ions from the GANEX solvent has been shown to be quite efficient using acetohydroxamic acid providing aqueous HNO3 concentrations are below ~0.3 M. In contrast, Np(V) shows much lower distribution ratios and is unstable in the GANEX solvent phase with quite rapid formation of Np(IV) observed. Closer analysis shows this to be due to Np(V) disproportionation, which is enhanced at higher organic phase acidities. Disproportionation of Np(V) is also shown to occur in separate TODGA and DMDOHEMA kerosene solutions. These observations thus enable conditions for neptunium extraction to be optimized during the design of a GANEX flowsheet.
No takes yet. Share an insight, caveat, or question.
Carrot et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: